AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51

Authors: ERTTMANN R TAFESE T BERTHOLD F KERBL R MANN J PARKER L SCHILLING F AMBROS P CHRISTIANSEN H FAVROT M KABISCH H HERO B PHILIP T
Citation: R. Erttmann et al., 10 YEARS NEUROBLASTOMA SCREENING IN EUROPE - PRELIMINARY-RESULTS OF ACLINICAL AND BIOLOGICAL REVIEW FROM THE STUDY-GROUP FOR EVALUATION OFNEUROBLASTOMA SCREENING IN EUROPE (SENSE), European journal of cancer, 34(9), 1998, pp. 1391-1397

Authors: OELSSNER W BERTHOLD F KADEN H
Citation: W. Oelssner et al., INVESTIGATION OF CORROSION ON CHEMICAL SENSORS BY MEANS OF ELECTROCHEMICAL NOISE-ANALYSIS, Werkstoffe und Korrosion, 49(9), 1998, pp. 700-704

Authors: KUROWSKI C BERTHOLD F
Citation: C. Kurowski et F. Berthold, PRESENCE OF CLASSICAL MULTIDRUG-RESISTANCE AND P-GLYCOPROTEIN EXPRESSION IN HUMAN NEUROBLASTOMA-CELLS, Annals of oncology, 9(9), 1998, pp. 1009-1014

Authors: KUHL J MULLER L BERTHOLD F KORTMANN RD DEINLEIN F MAASS E GRAF N GNEKOW A SCHEURLEN W GOBEL U WOLFF JEA BAMBERG M KAATSCH P KLEIHUES P RATING D SORENSEN N WIESTLER OD
Citation: J. Kuhl et al., PRERADIATION CHEMOTHERAPY OF CHILDREN AND YOUNG-ADULTS WITH MALIGNANTBRAIN-TUMORS - RESULTS OF THE GERMAN PILOT TRIAL HIT88 89/, Klinische Padiatrie, 210(4), 1998, pp. 227-233

Authors: LADENSTEIN R MATTHAY K BERTHOLD F KOGNER P PEARSON ADJ FRAPPAZ D DEBERNARDI B YAMAMOTO K HARTMANN O
Citation: R. Ladenstein et al., WHAT CAN WE EXPECT FROM NEUROBLASTOMA SCREENING - CLINICIAN POINT-OF-VIEW, Medical and pediatric oncology, 31(5), 1998, pp. 408-418

Authors: SCHILLING FH SPIX C BERTHOLD F ERTTMANN R HERO B MICHAELIS J SANDER J TAFESE T TREUNER J
Citation: Fh. Schilling et al., GERMAN NEUROBLASTOMA MASS-SCREENING STUDY AT 12 MONTHS OF AGE - STATISTICAL ASPECTS AND PRELIMINARY-RESULTS, Medical and pediatric oncology, 31(5), 1998, pp. 435-441

Authors: HILKER R MIELKE R BERTHOLD F SCHRODER R HEISS WD
Citation: R. Hilker et al., DIAGNOSIS AND THERAPY OF MIXED PINEALOMAS CONSISTING IN PART OF SECRETING GERM-CELL TUMORS, Nervenarzt, 69(6), 1998, pp. 519-524

Authors: RUDOLPH P BERTHOLD F PARWARESCH R HARMS D SCHMIDT D
Citation: P. Rudolph et al., PROLIFERATION MARKER KI-S5 IS AN INDEPENDENT PROGNOSTIC INDICATOR FORNEUROBLASTOMA, Journal of pathology, 184, 1998, pp. 10-10

Authors: BERTHOLD F LINDFORS EL GELLERSTEDT G
Citation: F. Berthold et al., DEGRADATION OF GUAIACYLGLYCEROL-BETA-GUAIACYL ETHER IN THE PRESENCE OF NAHS OR POLYSULFIDE AT VARIOUS ALKALINITIES - PART II - LIBERATION OF CONIFERYL ALCOHOL AND SULFUR, Holzforschung, 52(5), 1998, pp. 481-489

Authors: BERTHOLD F GELLERSTEDT G
Citation: F. Berthold et G. Gellerstedt, INFLUENCE OF POLYSULFIDE ON THE RATE OF DEGRADATION OF 6 P-OH STYRENESTRUCTURES AT 2 OH- CONCENTRATIONS, Holzforschung, 52(5), 1998, pp. 490-498

Authors: BERTHOLD F LINDFORS EL GELLERSTEDT G
Citation: F. Berthold et al., DEGRADATION OF GUAIACYLGLYCEROL-BETA-GUAIACYL ETHER IN THE PRESENCE OF HS- OR POLYSULFIDE AT VARIOUS ALKALINITIES PART-I - DEGRADATION RATEAND THE FORMATION OF ENOL ETHER, Holzforschung, 52(4), 1998, pp. 398-404

Authors: BERTHOLD F LINDGREN CT LINDSTROM ME
Citation: F. Berthold et al., FORMATION OF (4-HYDROXY-3-METHOXYPHENYL)-GLYOXYLIC ACID AND (4-HYDROXY-3,5-DIMETHOXYPHENYL)-GLYOXYLIC ACID DURING POLYSULFIDE TREATMENT OF SOFTWOOD AND HARDWOOD, Holzforschung, 52(2), 1998, pp. 197-199

Authors: BERTHOLD F
Citation: F. Berthold, NEUROBLASTOMA - COMMENTARY, European journal of cancer, 33(9), 1997, pp. 1437-1438

Authors: BERTHOLD F SAHIN K HERO B CHRISTIANSEN H GEHRING M HARMS D HORZ S LAMPERT F SCHWAB M TERPE J
Citation: F. Berthold et al., THE CURRENT CONTRIBUTIONAL OF MOLECULAR FACTORS TO RISK-ESTIMATION INNEUROBLASTOMA PATIENTS, European journal of cancer, 33(12), 1997, pp. 2092-2097

Authors: CASTLEBERRY RP PRITCHARD J AMBROS P BERTHOLD F BRODEUR GM CASTEL V COHN SL DEBERNARDI B DICKSMIREAUX C FRAPPAZ D HAASE GM HABER M JONES DR JOSHI VV KANEKO M KEMSHEAD JT KOGNER P LEE REJ MATTHAY KK MICHON JM MONCLAIR R ROALD BR SEEGER RC SHAW PJ SHIMADA H SHUSTER JJ
Citation: Rp. Castleberry et al., THE INTERNATIONAL NEUROBLASTOMA RISK GROUPS (INRG) - A PRELIMINARY-REPORT, European journal of cancer, 33(12), 1997, pp. 2113-2116

Authors: FICHTNER I LEMM M BECKER M BERTHOLD F
Citation: I. Fichtner et al., EFFECTS OF AMIFOSTINE (WR-2721, ETHYOL) ON TUMOR-GROWTH AND PHARMACOLOGY OF CYTOTOXIC DRUGS IN HUMAN XENOTRANSPLANTED NEUROBLASTOMAS, Anti-cancer drugs, 8(2), 1997, pp. 174-181

Authors: FULDA S OSTER W BERTHOLD F
Citation: S. Fulda et al., EFFECTS OF WR-2721 (AMIFOSTINE) AND ITS METABOLITE WR-1065 ON THE ANTIPROLIFERATIVE ACTIVITY OF CHEMOTHERAPEUTIC-AGENTS ON NEUROBLASTOMA-CELLS IN-VITRO, Anti-cancer drugs, 8(1), 1997, pp. 34-41

Authors: HERO B KREMENS B KLINGEBIEL T BENDERGOTZE C BURDACH S SCHRAPPE M BERTHOLD F
Citation: B. Hero et al., DOES MEGATHERAPY CONTRIBUTE TO SURVIVAL IN METASTATIC NEUROBLASTOMA -A RETROSPECTIVE ANALYSIS, Klinische Padiatrie, 209(4), 1997, pp. 196-200

Authors: LAMPERT F CHRISTIANSEN H BERNER F TERPE HJ BERTHOLD F
Citation: F. Lampert et al., DISSEMINATED NEUROBLASTOMAS UNDER 1 YEAR OF AGE - CELL BIOLOGY AND PROGNOSIS, Journal of neuro-oncology, 31(1-2), 1997, pp. 181-184

Authors: VOGES J STURM V LEHRKE R TREUER H GAUSS C BERTHOLD F
Citation: J. Voges et al., CYSTIC CRANIOPHARYNGIOMA - LONG-TERM RESULTS AFTER INTRACAVITARY IRRADIATION WITH STEREOTAXICALLY APPLIED COLLOIDAL BETA-EMITTING RADIOACTIVE SOURCES, Neurosurgery, 40(2), 1997, pp. 263-269

Authors: PIETSCH T WAHA A KOCH A KRAUS J ALBRECHT S TONN J SORENSEN N BERTHOLD F HENK B SCHMANDT N WOLF HK VONDEIMLING A WAINWRIGHT B CHENEVIXTRENCH G WIESTLER OD WICKING C
Citation: T. Pietsch et al., MEDULLOBLASTOMAS OF THE DESMOPLASTIC VARIANT CARRY MUTATIONS OF THE HUMAN HOMOLOG OF DROSOPHILA PATCHED, Cancer research, 57(11), 1997, pp. 2085-2088

Authors: RUDOLPH P LAPPE T HERO B BERTHOLD F PARWARESCH R HARMS D SCHMIDT D
Citation: P. Rudolph et al., PROGNOSTIC-SIGNIFICANCE OF THE PROLIFERATIVE ACTIVITY IN NEUROBLASTOMA, The American journal of pathology, 150(1), 1997, pp. 133-145

Authors: FAVROT MC AMBROS P SCHILLING F FRAPPAZ D COMBARET V BERTHOLD F DOMINICI C ERTTMANN R ESTEVE J JENKNER A KERBL R MANN J MATHIEU P PARKER L POWELL J PHILIP T
Citation: Mc. Favrot et al., COMPARISON OF THE DIAGNOSTIC AND PROGNOSTIC VALUE OF BIOLOGICAL MARKERS IN NEUROBLASTOMA - PROPOSAL FOR A COMMON METHODOLOGY, Annals of oncology, 7(6), 1996, pp. 607-611

Authors: BERTHOLD F HERO B BREU H CHRISTIANSEN H ERTTMANN R GNEKOW A HERRMANN F KLINGEBIEL T LAMPERT F MULLERWEIRICH S WEINEL P
Citation: F. Berthold et al., THE RECURRENCE PATTERNS OF STAGE-I, STAGE-II AND STAGE-III NEUROBLASTOMA - EXPERIENCE WITH 77 RELAPSING PATIENTS, Annals of oncology, 7(2), 1996, pp. 183-187

Authors: MICHAELIS J HAAF HG ZOLLNER J KAATSCH P KRUMMENAUER F BERTHOLD F
Citation: J. Michaelis et al., CASE-CONTROL STUDY OF NEUROBLASTOMA IN WEST-GERMANY AFTER THE CHERNOBYL ACCIDENT, Klinische Padiatrie, 208(4), 1996, pp. 172-178
Risultati: 1-25 | 26-50 | 51-51